Hi Triage, the cost of manufacturing a drug once it has been trialed and validated (i.e. through trials, failures etc) is low. The margins are high on the product. Hence why big pharma scoops up companies like $BOT who have done the hard work, with the big RnD spends.....
You're right. Sorry if I wasn't clear.
-
- There are more pages in this discussion • 5,396 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $256.1M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.5¢ | $579.7K | 4.556M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 1051231 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 650262 | 14 |
View Market Depth
| Last trade - 16.10pm 07/11/2025 (20 minute delay) ? |
| BOT (ASX) Chart |